SKOOTS: Skeleton‐Oriented Object Segmentation for Mitochondria in High‐Resolution Cochlear EM Datasets
Advanced Science · 2026-06 · 13 (32)
DOI: 10.1002/advs.202517738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.03.2026. Verfasst von Christopher J Buswinka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eaton Peabody Laboratories, Mass Eye and Ear, Boston, MA, USA. Hauptthemen laut MEDLINE: Mitochondria, Imaging, Three-Dimensional, Cochlea, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, National Science Foundation, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Segmenting individual instances of mitochondria from imaging datasets can provide rich quantitative information, but manual segmentation is prohibitively time‐consuming—prompting the development of automated algorithms based on deep neural networks. Existing solutions for various segmentation tasks are optimized for either: high‐resolution three‐dimensional imaging, relying on well‐defined object boundaries (e.g., whole neuron segmentation in volumetric electron microscopy datasets); or low‐resolution two‐dimensional imaging, boundary‐invariant but poorly suited to large 3D objects (e.g., whole‐cell segmentation of light microscopy images). However, there is a middle ground that challenges current segmentation tools: large 3D objects with ambiguous boundaries, such as mitochondria in whole‐cell 3D electron microscopy datasets. To address this, we developed Sk eleton‐ O riented O bjec t S egmentation (SKOOTS)—a novel, general‐purpose 3D segmentation framework for efficiently segmenting densely packed, morphologically complex objects. SKOOTS is fast, accurate, and memory‐efficient, and can be applied to segment mitochondria and other structures in both 3D light and electron microscopy datasets. By combining skeleton‐based instance segmentation with a scalable embedding approach, SKOOTS bridges a key gap in existing segmentation strategies and enables biologically meaningful, large‐scale analysis of 3D biomedical imaging data. We demonstrate this by segmenting >15 000 mitochondria from cochlear hair cells and supporting cells across experimental conditions in under 2 h on a consumer‐grade PC, enabling downstream morphological analysis that revealed subtle structural changes following aminoglycoside exposure. SKOOTS is fully open‐source, easy to retrain, and designed to support diverse datasets, making it broadly accessible to the research community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eaton Peabody Laboratories, Mass Eye and Ear, Boston, MA, USA.
- Department of Otolaryngology, Head and Neck Surgery, Harvard Medical School, Boston, MA, USA.
- Speech and Hearing Biosciences and Technology graduate Program, Harvard University, Cambridge, MA, USA.
ORCID-Profile: Christopher J Buswinka, Richard T Osgood, Artur A Indzhykulian
Förderung
- NIDCD NIH HHS
- National Science Foundation
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
Buswinka, C. J., Osgood, R. T., Nitta, H., & Indzhykulian, A. A. (2026). SKOOTS: Skeleton‐Oriented Object Segmentation for Mitochondria in High‐Resolution Cochlear EM Datasets. Advanced Science, 13(32). https://doi.org/10.1002/advs.202517738
Vancouver
Buswinka CJ, Osgood RT, Nitta H, Indzhykulian AA. SKOOTS: Skeleton‐Oriented Object Segmentation for Mitochondria in High‐Resolution Cochlear EM Datasets. Advanced Science. 2026;13(32). doi:10.1002/advs.202517738
BibTeX
@article{Buswinka2026,
author = {Buswinka, Christopher J and Osgood, Richard T and Nitta, Hidetomi and Indzhykulian, Artur A},
title = {SKOOTS: Skeleton‐Oriented Object Segmentation for Mitochondria in High‐Resolution Cochlear EM Datasets},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {32},
doi = {10.1002/advs.202517738}
}
EUVIMED